#aurobinbo pharma Tech News.
1 story in the last 7 days
The latest aurobinbo pharma news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks aurobinbo pharma across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
FinanceET Techabout 5 hours ago
Aurobindo gets FTC nod for Lannett Co acquisitionAurobindo Pharma's US arm received Federal Trade Commission approval for its $250 million acquisition of Lannett Company. The deal, expected to close by June 2026, strengthens Aurobindo's complex generics and controlled substances portfolio and adds Lannett's Indiana manufacturing facility. The acquisition is projected to immediately boost earnings per share.
Summaries by ByteBrief